A growing number of cystic fibrosis patients are struggling with drug costs due to a battle between drugmakers and insurers.
Kim Raff for STAT 'Caught in the middle': A battle between Vertex and insurers is leaving cystic fibrosis patients with crushing drug costs A growing number of cystic fibrosis patients and their families like the Brickeys (above) are encountering sharp jumps in their out-of-pocket drug costs thanks to a grinding, behind-the-scenes struggle taking place between pharmaceutical companies and health insurers across the U.S. Read more. By Ed Silverman |
|
Eros Dervishi for STAT How a depression test devised by a Zoloft marketer became a crutch for a failing mental health system A bedrock of the U.S. mental health system — a nine-item questionnaire used to spot depression — began not with a doctor, but with a marketer. In an overstretched health care system warped by business interests, a STAT investigation shows how this simple tool has become a crutch — used in place of, rather than as a gateway to, thoughtful mental health care. Read more. By Olivia Goldhill Alissa Ambrose/STAT Cereal, pasta, and other food companies blast the FDA for a too-strict definition of 'healthy' General Mills, Kellogg's, and the rest of the country's cereal makers are mad at the FDA. So are the packaged food companies, the pasta industry, and the pickle lobby. The companies behind America's favorite culinary indulgences are worried their products wouldn't be considered "healthy" under a recent FDA proposal — and they're urging regulators to reconsider. Read more. By Nicholas Florko More great reads from STAT this week |
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2023, All Rights Reserved. | |
|
No comments